A study of HDV in HBsAg positive patients in Tabriz, Northwestern Iran

Hepatitis Monthly

Volumn 10, Issue 2, 2010, Pages 110-115

  Seifi, Sirus Jedary ^a   Ghannad, Masoud Sabouri ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Haemophilia; HDV; Hemodialysis; Intravenous drug users; Thalassemia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN M ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DONOR; DELTA AGENT HEPATITIS; ENDEMIC DISEASE; HEMODIALYSIS PATIENT; HEMOPHILIA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; INFECTION CONTROL; INFECTION RISK; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SEROPREVALENCE; THALASSEMIA; VIRUS TRANSMISSION;

EID: 77954880622     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Nair S, Perillo RP. Hepatitis B and D. In: Zakim D, Boyer TD, editors. Hepatology. 4th ed. Philadelphia: WB Saunders; 2003. p. 959-1016.
2. Alter M. Epidemiology of hepatitis B infection in the Western Pacific and South-East Asia. Gut. 1976;38(Suppl 2):S18-23.
3. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med. 2000;3(4):192-201.
4. Hassanjani-Roshan MR, Taheri H. Frequency of chronic active hepatitis in asymptomatic HBV carriers in Babol, Iran. Arch Iran Med. 2002;5(2):97-9.
5. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology. 1985;5(2):188-91.
6. Kawai M, Feinstone S. Acute Viral Hepatitis. In: Mandell G, Bennett J, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. New York: Churchill Livingstone; 1999. p. 828-1287.
7. Fiedler M, Lu M, Siegel F, Whipple J, Roggendorf M. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine. Vaccine. 2001;19(32):4618-26.
8. Brooks G, Carroll K, Butel J, Morse S. Jawetz, Melnick & Adelberg's Medical Microbiology. 24th ed. New York McGraw-Hill; 2007.
9. Toukan AU, al-Kandari S. The role of hepatitis D virus in liver disease in the Middle East. Prog Clin Biol Res. 1991;364:63-8.
10. Ivaniushina VA, Ryzhova EV, Grudinin MP, et al. [The frequency of antibodies against delta virus in patients with HBs positive hepatitis]. Vopr Virusol. 1996;41(4):166-9.
11. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology. 2000;32(4 Pt 1):824-7.
12. Tapalaga D, Forzani B, Hele C, Paravacini O, Ponzetto A, Theilmann L. Prevalence of the hepatitis delta virus in Rumania. Hepatogastroenterology. 1986;33(6):238-9.
13. Chakraborty P, Kailash U, Jain A, et al. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. Indian J Med Res. 2005;122(3):254-7.
14. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med. 1994;330(11):744-50.
15. Torabi S, Ebrahim-poor S, Maljaie H, Naqili B. [Seroepidemiologic study on hepatitis delta virus among HBsAg positive subjects in Tabriz, Iran]. Urmia Med J. 2002;13:290-7.
16. Roshandel G, Semnani S, Abdolahi N, et al. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227-30.
17. Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection. 1990;18(1):26-8.
18. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993;96(5):277-87.
19. Alavian SM, Assari S, Manzoori-Joybari H, et al. [Frequency and risk factors of hepatitis D virus in hepatitis B patients]. Govaresh. 2005;10(1):21-6.
20. Zaki H, Darmstadt GL, Baten A, Ahsan CR, Saha SK. Seroepidemiology of hepatitis B and delta virus infections in Bangladesh. J Trop Pediatr. 2003;49(6):371-4.
21. Mumtaz K, Hamid SS, Adil S, et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol. 2005;20(10):1503-7.
22. Munoz Espinosa LE, Ibarra Salas MJ. [Prevalence of hepatitis D in a population of Northeast Mexico and its relationship with other viruses]. Rev Gastroenterol Mex. 1997;62(4):246-9.
23. Chen CJ, Tseng SF, Lu CF, et al. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan. J Med Virol. 1992;38(2):97-101.
24. de Miguel J, Collazos J, Mayo J, Lopez de Goicoechea MJ, Echaniz C, Mendarte U. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus]. Rev Clin Esp. 1994;194(10):897-900.
25. Delic D, Gotic M, Ostric V, et al. Epidemiology of hepatitis D virus (delta) infection in Yugoslavia. Liver. 1993;13(6):302-4.
26. Amarapurkar DN, Kumar A, Vaidya S, et al. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics. Indian J Gastroenterol. 1992;11(2):80-1.
27. Mollah AH, Nahar N, Siddique MA, Anwar KS, Hassan T, Azam MG. Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh. J Health Popul Nutr. 2003;21(1):67-71.
28. Huo TI, Wu JC, Wu SI, et al. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations. J Med Virol. 2004;72(1):41-5.
29. Cross TJ, Rizzi P, Horner M, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. 2008;80(2):277-82.
30. Lusida MI, Surayah, Sakugawa H, et al. Genotype and subtype analyses of hepatitis B virus (HBV) and possible co-infection of HBV and hepatitis C virus (HCV) or hepatitis D virus (HDV) in blood donors, patients with chronic liver disease and patients on hemodialysis in Surabaya, Indonesia. Microbiol Immunol. 2003;47(12):969-75.
31. Navascues CA, Rodriguez M, Sotorrio NG, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol. 1995;90(11):1981-4.
32. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol. 1997;12(11):747-51.
33. Sagnelli E, Stroffolini T, Ascione A, et al. Decrease in HDV endemicity in Italy. J Hepatol. 1997;26(1):20-4.